DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes
2006

DR_SEQAN: Software for Evaluating HIV Drug Resistance

publication Evidence: moderate

Author Information

Author(s): César Garriga, Luis Menéndez-Arias

Primary Institution: Centro de Biología Molecular 'Severo Ochoa', Consejo Superior de Investigaciones Científicas – Universidad Autónoma de Madrid

Hypothesis

The study aims to develop a software tool that accurately interprets HIV drug resistance mutations.

Conclusion

DR_SEQAN is an effective tool for interpreting HIV genotypic resistance and provides consistent predictions with existing algorithms.

Supporting Evidence

  • DR_SEQAN provides expert advice on HIV genotypic resistance interpretation.
  • The program's predictions are consistent with phenotypic data.
  • It includes a database of drug susceptibility data from published studies.

Takeaway

DR_SEQAN is a computer program that helps doctors understand how HIV mutations affect drug resistance, making it easier to choose the right treatment.

Methodology

The software analyzes RT and PR sequences of HIV-1, predicts drug resistance using a rule-based algorithm, and compares results with phenotypic data.

Limitations

The program may not detect variants that comprise less than 20% of the total virus population.

Digital Object Identifier (DOI)

10.1186/1471-2334-6-44

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication